Literature DB >> 3006672

Characteristics of complement subcomponents C1r and C1s synthesized by Hep G2 cells.

A Reboul, J C Bensa, M G Colomb.   

Abstract

The association and activation states of complement subcomponents C1r and C1s biosynthesized by Hep G2 cells were studied. C1r and C1s are secreted in stoichiometric amounts; in the presence of Ca2+ they are associated in a complex that sediments similarly to plasma C1r2-C1s2. Both compounds are synthesized as monomer proteins of apparent Mr 86 000. C1r is secreted as a dimer. Secreted C1r is not autoactivatable but undergoes proteolysis by exogenous C1r; secreted C1s is also proteolysed by exogenous C1r. In the presence of immune-complex-bound C1q, secreted C1r and C1s are able to reconstitute C1, but normal activation requires extrinsic C1r2-C1s2.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3006672      PMCID: PMC1153062          DOI: 10.1042/bj2330559

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  Fluid phase activation of proenzymic C1r purified by affinity chromatography.

Authors:  C L Villiers; A M Duplaa; G J Arlaud; M G Colomb
Journal:  Biochim Biophys Acta       Date:  1982-01-04

2.  The role of immune complexes in the activation of the first component of human complement.

Authors:  R J Ziccardi
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

3.  A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement.

Authors:  R J Ziccardi
Journal:  J Immunol       Date:  1982-06       Impact factor: 5.422

4.  Studies on the precursor form of the first component of complement. II. Proteolytic fragmentation of Clr.

Authors:  S N Assimeh; R M Chapuis; H Isliker
Journal:  Immunochemistry       Date:  1978-01

5.  Isolation and characterization of different forms of C1-r, a subcomponent of the first component of human complement.

Authors:  K Okamura; S Fujii
Journal:  Biochim Biophys Acta       Date:  1978-06-21

6.  Diamine-induced dissociation of the first component of human complement, C1.

Authors:  C L Villiers; G J Arlaud; M G Colomb
Journal:  Eur J Biochem       Date:  1984-04-16

7.  Purified proenzyme C1r. Some characteristics of its activation and subsequent proteolytic cleavage.

Authors:  G J Arlaud; C L Villiers; S Chesne; M G Colomb
Journal:  Biochim Biophys Acta       Date:  1980-11-06

8.  Complement biosynthesis by the human hepatoma-derived cell line HepG2.

Authors:  K M Morris; D P Aden; B B Knowles; H R Colten
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

9.  Biosynthesis in vitro of complement subcomponents C1q, C1s and C1 inhibitor by resting and stimulated human monocytes.

Authors:  J C Bensa; A Reboul; M G Colomb
Journal:  Biochem J       Date:  1983-11-15       Impact factor: 3.857

Review 10.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983
View more
  5 in total

1.  Biosynthesis of complement C1 inhibitor by Hep G2 cells. Reactivity of different glycosylated forms of the inhibitor with C1s.

Authors:  M H Prandini; A Reboul; M G Colomb
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

2.  Cloning and sequencing of full-length cDNA encoding the precursor of human complement component C1r.

Authors:  A Journet; M Tosi
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

3.  Identification of a human non-interferon lymphokine activating monocyte complement biosynthesis.

Authors:  C Drouet; A Reboul; M Colomb
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

4.  Prohaptoglobin is proteolytically cleaved in the endoplasmic reticulum by the complement C1r-like protein.

Authors:  Krzysztof B Wicher; Erik Fries
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-22       Impact factor: 11.205

5.  A New Tool for Complement Research: In vitro Reconstituted Human Classical Complement Pathway.

Authors:  Michele Mutti; Katharina Ramoni; Gábor Nagy; Eszter Nagy; Valéria Szijártó
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.